Stent customization system and method

• US 20070294210A1
• Filed: 09/22/2006
• Published: 12/20/2007
• Est. Priority Date: 06/16/2006
• Status: Abandoned Application

• Current Assignee: Searete LLC (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Jung, Edward K.Y., Langer, Robert, Leuthardt, Eric C., Levien, Royce A., Lord, Robert W., Malamud, Mark A., Rinaldo, John D., Tegreene, Clarence T., Wood, Lowell L.
• Application Number:
  US11/526,089
• Publication Number:
  US 20070294210A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 1/00082 Balloons
• CPC Class Codes: A61B 1/05 characterised by the image sensor, e.g. camera, being in the distal end portion
• CPC Class Codes: A61B 1/3137 for examination of the interior of blood vessels
• CPC Class Codes: A61B 5/0215 by means inserted into the body catheters A61M25/00
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 8/08 Detecting organic movements or changes, e.g. tumours, cysts, swellings A61B8/02 - A61B8/06 take precedence
• CPC Class Codes: A61B 8/4416 related to combined acquisition of different diagnostic modalities, e.g. combination of ultrasound and X-ray acquisitions
• CPC Class Codes: A61F 2/82 Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95; for closing wounds, or holding wounds closed A61B17/04 - A61B17/115; dilators A61M29/00
• CPC Class Codes: A61F 2/844 folded prior to deployment
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: G06Q 40/08 Insurance
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders

Abstract

Methods and systems are described for receiving a parameter relating to a specific patient, and for customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient or for customizing one or more junctions of a stent ex situ in response to the received parameter relating to the specific patient.

Claims

1. A method comprising:

receiving a parameter relating to a specific patient; and

customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient.

2. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving a heuristic model identifier as the parameter relating to the specific patient.

3. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving an identifier of the specific patient with the parameter relating to the specific patient.

4. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving a composite material identifier as the parameter relating to the specific patient.

5. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

selecting a template responsive to the parameter relating to the specific patient; and

customizing the selected template responsive to other information relating to the specific patient.

6. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing a material composition of the stent responsive to the parameter relating to the specific patient.

7. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing one or more apertures of the stent responsive to the parameter relating to the specific patient.

8. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

associating a medication regimen with the specific patient; and

implementing the medication regimen associated with the specific patient ex situ.

9. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing a dosage of a portion of the stent responsive to the parameter relating to the specific patient.

10. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving an indication of a digestive system structure as the parameter relating to the specific patient.

11. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving one or more dimensions including at least the parameter relating to the specific patient.

12. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving stent component quantity information with the parameter relating to the specific patient.

13. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

forming an antiproliferative surface of the stent; and

applying at least one of an anticoagulant or an anti-platelet agent to the stent after forming the antiproliferative surface of the stent.

14. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

bending a component of the stent ex situ as the at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient.

15. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

forming a flow occlusion portion of the stent responsive to the parameter relating to the specific patient.

16. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

modifying a stiffness of the stent responsive to the parameter relating to the specific patient.

17. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing the one or more attributes of the stent ex situ within one month of receiving the parameter relating to the specific patient.

18. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing the one or more attributes of the stent ex situ within one week of receiving the parameter relating to the specific patient.

19. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing the one or more attributes of the stent ex situ within one day of receiving the parameter relating to the specific patient.

20. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing the one or more attributes of the stent ex situ within one hour of receiving the parameter relating to the specific patient.

21. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

customizing the one or more attributes of the stent ex situ within at most about ten minutes of receiving the parameter relating to the specific patient.

22. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

retrieving a record including at least the parameter relating to the specific patient.

23. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

prompting user input; and

receiving the parameter relating to the specific patient via an interface after prompting the user input.

24. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving a pathological indication with the parameter relating to the specific patient.

25. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving shape information including at least the parameter relating to the specific patient.

27. The method of claim 1 further comprising:

marking the stent ex situ with identifying information relating to the one or more customized attributes of the stent.

28. The method of claim 1 further comprising:

aggregating data including at least the parameter relating to the specific patient and other information in a database.

29. The method of claim 1 further comprising:

recording an identifier of the stent with the parameter relating to the specific patient.

30. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving information at least partly relating to a stent inventory shortage including at least the parameter relating to the specific patient.

31. The method of claim 1 in which receiving a parameter relating to a specific patient comprises:

receiving an indication of a linkage between the parameter and the specific patient.

32. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

configuring one or more lateral sleeves in a portion of the stent responsive to the parameter relating to the specific patient.

33. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

configuring one or more pleats of the stent ex situ responsive to the parameter relating to the specific patient.

34. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

combining at least a first stent component and a second stent component responsive to information including at least the parameter relating to the specific patient.

35. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

cutting one or more flow holes in a component of the stent responsive to the parameter relating to the specific patient.

36. The method of claim 1 in which customizing one or more attributes of a stent ex situ as an at-least-roughly contemporaneous response to receiving the parameter relating to the specific patient comprises:

including an antibiotic on the stent responsive to the parameter relating to the specific patient.

26. (canceled)